+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medherant Ltd - Product Pipeline Analysis, 2020 Update

  • PDF Icon

    Company Profile

  • 30 Pages
  • January 2021
  • GlobalData
  • ID: 4594693
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormone therapy, and others. Its TEPI patch technology enables the production of patches with effective doses of active ingredients with enhanced long-term drug delivery. Medherant provides high drug loading patches for ibuprofen transdermal and methyl salicylate delivery. The company works in partnership with other companies such as AdhexPharma and Bostik to manufacture TEPI Patch products. It is a spinoff of the University of Warwick. Medherant is headquartered in Coventry, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Medherant Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Medherant Ltd Company Overview
  • Medherant Ltd Company Snapshot
  • Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview

Medherant Ltd - Pipeline Analysis OverviewMedherant Ltd - Key FactsMedherant Ltd - Major Products and Services
Medherant Ltd Pipeline Products by Development Stage
  • Medherant Ltd Pipeline Products Overview
  • Diclofenac TEPI Patch
  • Diclofenac TEPI Patch Product Overview
  • Donepezil TEPI Patch
  • Donepezil TEPI Patch Product Overview
  • Dronabinol TEPI Patch
  • Dronabinol TEPI Patch Product Overview
  • Ibuprofen TEPI Patch
  • Ibuprofen TEPI Patch Product Overview
  • Lidocaine TEPI Patch
  • Lidocaine TEPI Patch Product Overview
  • Memantine TEPI Patch
  • Memantine TEPI Patch Product Overview
  • Methyl Salicylate TEPI Patch
  • Methyl Salicylate TEPI Patch Product Overview

Medherant Ltd - Key CompetitorsMedherant Ltd - Key Employees
Medherant Ltd - Locations And Subsidiaries
  • Head Office

Recent Developments
  • Medherant Ltd, Recent Developments
  • Jun 25, 2019: Medherant positions itself for the next stage of its development with the appointment of a new CEO
  • Jun 25, 2019: Medherant positions itself for the next stage of its development with the appointment of a new CEO
  • Nov 05, 2018: Medherant announces positive phase I results for its first transdermal drug delivery patch
  • Oct 03, 2018: Medherant has been awarded a medicines manufacturing grant by Innovate UK
  • Oct 03, 2018: Innovate UK awards Medherant a medicines manufacturing grant
  • Mar 07, 2018: Medherant expands team with appointment of David Davies as Head of Development
  • Nov 17, 2017: Medherant wins Excellence in Science & Technology Award
  • Oct 18, 2017: Warwick graduate invents revolutionary device for testing drugs
  • Sep 26, 2017: Medherant Signs Agreement with Leading Japanese Transdermal Patch Company for Evaluation of Its TEPI Patch Drug Delivery System
  • Jun 26, 2017: Medherant appoints new COO and CFO

  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer

List of Tables
  • Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Medherant Ltd Pipeline Products by Equipment Type
  • Medherant Ltd Pipeline Products by Indication
  • Medherant Ltd, Key Facts
  • Medherant Ltd, Major Products and Services
  • Medherant Ltd Number of Pipeline Products by Development Stage
  • Medherant Ltd Pipeline Products Summary by Development Stage
  • Diclofenac TEPI Patch - Product Status
  • Diclofenac TEPI Patch - Product Description
  • Donepezil TEPI Patch - Product Status
  • Donepezil TEPI Patch - Product Description
  • Dronabinol TEPI Patch - Product Status
  • Dronabinol TEPI Patch - Product Description
  • Ibuprofen TEPI Patch - Product Status
  • Ibuprofen TEPI Patch - Product Description
  • Lidocaine TEPI Patch - Product Status
  • Lidocaine TEPI Patch - Product Description
  • Memantine TEPI Patch - Product Status
  • Memantine TEPI Patch - Product Description
  • Methyl Salicylate TEPI Patch - Product Status
  • Methyl Salicylate TEPI Patch - Product Description
  • Medherant Ltd, Key Employees
  • Glossary

List of Figures
  • Medherant Ltd Pipeline Products by Equipment Type
  • Medherant Ltd Pipeline Products by Development Stage



Companies Mentioned

A selection of companies mentioned in this report includes:

  • Nemaura Pharma Ltd
  • MedPharm Ltd
  • 3M Health Care Ltd